Overview
- The Sept. 29 Breakpoint overhaul briefly lifted engagement, yet sales still failed to meet Remedy’s internal goals.
- Remedy recorded a €14.9 million non-cash impairment covering most capitalised development and purchased publishing and distribution rights, with no effect on cash.
- The company now expects 2025 revenue to rise but says operating profit will be negative and below the prior year.
- Launched June 17, the shooter reached about 1 million players largely through console subscription deals as Steam concurrency fell from under 2,000 at release to double digits within weeks.
- CEO Tero Virtala said development will continue with spending aligned to the revised forecast, with further details expected in the Oct. 29 quarterly report.